Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

17.73
Delayed Data
As of Oct 20
 +0.13 / +0.74%
Today’s Change
14.36
Today|||52-Week Range
31.85
-13.26%
Year-to-Date

Today’s Trading

Previous close17.60
Today’s open17.76
Day’s range17.31 - 17.85
Volume247,097
Average volume (3 months)241,879
Market cap$652.4M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-168.25%
Earnings growth (this year)-155.66%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.90%
P/E ratioNM
Price/Sales7.72
Price/Book2.30

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-0.30-1.22%
ALDRAlder Biopharmaceuti...0.000.00%
SGYPSynergy Pharmaceutic...-0.01-0.35%
DOVADova Pharmaceuticals...-0.40-1.47%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$1.05
Annual revenue (last year)$91.9M
Annual profit (last year)-$58.5M
Net profit margin-63.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
Senior VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts